Lataa...
Exploiting gene expression profiling to identify novel minimal residual disease markers of neuroblastoma
PURPOSE: Minimal residual disease (MRD) presents a significant hurdle to curing metastatic neuroblastoma (NB). Biologic therapies directed against MRD can improve outcome. Evaluating treatment efficacy requires MRD measurement, which serves as surrogate endpoint. Because of tumor heterogeneity, no s...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2670609/ https://ncbi.nlm.nih.gov/pubmed/18980998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0541 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|